Invesco LLC Cuts Stock Position in Humana Inc. (NYSE:HUM)

Invesco LLC decreased its holdings in Humana Inc. (NYSE:HUM) by 47.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,271 shares of the insurance provider’s stock after selling 2,023 shares during the quarter. Invesco LLC’s holdings in Humana were worth $601,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in HUM. Revolve Wealth Partners LLC acquired a new stake in shares of Humana in the fourth quarter valued at $202,000. Sanctuary Advisors LLC increased its holdings in Humana by 17.3% during the 4th quarter. Sanctuary Advisors LLC now owns 8,533 shares of the insurance provider’s stock worth $2,165,000 after purchasing an additional 1,258 shares during the period. Truist Financial Corp raised its position in Humana by 15.6% in the 4th quarter. Truist Financial Corp now owns 8,865 shares of the insurance provider’s stock valued at $2,249,000 after purchasing an additional 1,199 shares in the last quarter. D.A. Davidson & CO. boosted its stake in shares of Humana by 19.0% in the 4th quarter. D.A. Davidson & CO. now owns 1,283 shares of the insurance provider’s stock valued at $326,000 after buying an additional 205 shares during the period. Finally, Atria Wealth Solutions Inc. grew its position in shares of Humana by 21.1% during the fourth quarter. Atria Wealth Solutions Inc. now owns 1,610 shares of the insurance provider’s stock worth $409,000 after buying an additional 281 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Bank of America reduced their target price on shares of Humana from $320.00 to $260.00 and set a “neutral” rating on the stock in a report on Tuesday, June 17th. Raymond James Financial upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $315.00 price objective on the stock in a report on Thursday, May 1st. Oppenheimer increased their target price on Humana from $300.00 to $310.00 and gave the company an “outperform” rating in a report on Thursday, May 1st. Robert W. Baird raised their price target on Humana from $270.00 to $300.00 and gave the company a “neutral” rating in a research note on Tuesday, April 15th. Finally, Barclays set a $268.00 price objective on Humana and gave the stock an “equal weight” rating in a research report on Thursday, June 12th. Seventeen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $280.76.

Humana Price Performance

Shares of NYSE:HUM opened at $234.81 on Tuesday. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.71. The company has a 50-day moving average price of $244.77 and a 200 day moving average price of $260.35. Humana Inc. has a 52 week low of $212.45 and a 52 week high of $406.46. The company has a market cap of $28.34 billion, a P/E ratio of 16.61, a PEG ratio of 1.81 and a beta of 0.43.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts’ consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 14.47% and a net margin of 1.42%. Humana’s quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $7.23 earnings per share. Research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.51%. Humana’s payout ratio is 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.